Form D · Pharmaceuticals

Theseus Pharmaceuticals, Inc.

Cambridge, MA · CIK 0001745020

Offering snapshot reported Feb 4, 2021 · SEC filing

Reported sold
$22.1M
Offering amount: $22.1M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 14, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11.1M$22.1MJun 29, 2018: $5,000,000.00Jun 29, 2018Feb 4, 2021: $22,136,987.00Feb 4, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,000,000 → $22,136,987

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 4, 2021Amendment$22,136,987$17,136,987vs Jun 29, 20183SEC filing
Feb 4, 2021Initial$95,099,957No comparison16SEC filing
Jun 29, 2018Initial$5,000,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-315789

Source: Form D, filed Feb 4, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Iain Dukes Director, Executive
Carl Gordon Director
Michael Rome Director
William C. Shakespeare Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
210 Broadway, Suite 201
Cambridge, MA, 02139